Terns Pharmaceuticals, Inc. (NASDAQ: TERN) reported Q4 EPS of ($0.24), $0.06 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Terns Pharmaceuticals, Inc. (TERN) click here.